BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status

被引：0
|
作者：
M. Jansen
I. Christiaans
S. N. van der Crabben
M. Michels
R. Huurman
Y. M. Hoedemaekers
D. Dooijes
J. D. H. Jongbloed
L. G. Boven
R. H. Lekanne Deprez
A. A. M. Wilde
J. J. M. Jans
J. van der Velden
R. A. de Boer
J. P. van Tintelen
F. W. Asselbergs
A. F. Baas
机构：
[1] Utrecht University,Department of Genetics, University Medical Centre Utrecht
[2] University of Groningen,Department of Genetics, University Medical Centre Groningen
[3] University of Amsterdam,Department of Clinical Genetics, Amsterdam UMC
[4] Erasmus University Medical Centre,Department of Cardiology, Thoraxcenter
[5] Radboud University Medical Centre,Department of Clinical Genetics
[6] University of Amsterdam,Heart Centre, Clinical and Experimental Cardiology, Amsterdam UMC
[7] Vrije Universiteit Amsterdam,Department of Physiology, Amsterdam UMC
[8] Amsterdam Cardiovascular Sciences,Department of Cardiology, University Medical Centre Groningen
[9] University of Groningen,Department of Cardiology
[10] Netherlands Heart Institute,Institute of Cardiovascular Science, Faculty of Population Health Sciences
[11] University Medical Centre Utrecht,Health Data Research UK and Institute of Health Informatics
[12] University College London,undefined
[13] University College London,undefined
来源：
Netherlands Heart Journal | 2021年 / 29卷
关键词：
Hypertrophic cardiomyopathy; MYBPC3; Biomarkers; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：318 / 329
页数：11
相关论文
共 50 条
  • [31] Plasma Natriuretic Peptide Levels Between Asymptomatic Carriers and Non-carriers of MYBPC3 Gene Mutation for Hypertrophic Cardiomyopathy
    Tang, Wai Hong Wilson
    Xin, Baozhong
    Nye, Leah
    Hazen, Stanley L.
    Wang, Heng
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A175 - A175
  • [32] Comparison of Cardiac and Inflammatory Biomarker Levels between Carriers and Non-Carriers of MYBPC3 Gene Mutation for Hypertrophic Cardiomyopathy
    Tang, W. H. Wilson
    Xin, Baozhong
    Nye, Leah
    De, Sabe
    Borowski, Allen G.
    Hazen, Stanley L.
    Wang, Heng
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (06) : S36 - S36
  • [33] Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy
    Warnecke, Nele
    Ulmer, Barbel M.
    Laufer, Sandra D.
    Shibamiya, Aya
    Kraemer, Elisabeth
    Neuber, Christiane
    Hanke, Sophia
    Behrens, Charlotta
    Loos, Malte
    Muench, Julia
    Kuehnisch, Jirko
    Klaassen, Sabine
    Eschenhagen, Thomas
    Patten-Hamel, Monica
    Carrier, Lucie
    Mearini, Giulia
    STEM CELL RESEARCH, 2021, 55
  • [34] Complex sarcomeric genetic status is not an important modifier of disease severity in MYBPC3 associated hypertrophic cardiomyopathy
    Van Tienhoven, M.
    Hoedemaekers, Y. M.
    Michels, M.
    Ten Cate, F. J.
    Majoor-Krakauer, D. F.
    Halley, D. J. J.
    Dooijes, D.
    EUROPEAN HEART JOURNAL, 2009, 30 : 542 - 542
  • [35] Compound heterozygosity deteriorates phenotypes of hypertrophic cardiomyopathy with founder MYBPC3 mutation: evidence from patients and zebrafish models
    Hodatsu, Akihiko
    Konno, Tetsuo
    Hayashi, Kenshi
    Funada, Akira
    Fujita, Takashi
    Nagata, Yoji
    Fujino, Noboru
    Kawashiri, Masa-aki
    Yamagishi, Masakazu
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2014, 307 (11): : H1594 - H1604
  • [36] Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction
    Timmer, Stefan A. J.
    Germans, Tjeerd
    Brouwer, Wessel P.
    Lubberink, Mark
    van der Velden, Jolanda
    Wilde, Arthur A. M.
    Christiaans, Imke
    Lammertsma, Adriaan A.
    Knaapen, Paul
    van Rossum, Albert C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (12) : 1283 - 1289
  • [37] Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations
    Pei, J.
    Schuldt, M.
    Nagyova, E.
    Gu, Z.
    el Bouhaddani, S.
    Yiangou, L.
    Jansen, M.
    Calis, J. J. A.
    Dorsch, L. M.
    Blok, C. Snijders
    van den Dungen, N. A. M.
    Lansu, N.
    Boukens, B. J.
    Efimov, I. R.
    Michels, M.
    Verhaar, M. C.
    de Weger, R.
    Vink, A.
    van Steenbeek, F. G.
    Baas, A. F.
    Davis, R. P.
    Uh, H. W.
    Kuster, D. W. D.
    Cheng, C.
    Mokry, M.
    van der Velden, J.
    Asselbergs, F. W.
    Harakalova, M.
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [38] Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations
    J. Pei
    M. Schuldt
    E. Nagyova
    Z. Gu
    S. el Bouhaddani
    L. Yiangou
    M. Jansen
    J. J. A. Calis
    L. M. Dorsch
    C. Snijders Blok
    N. A. M. van den Dungen
    N. Lansu
    B. J. Boukens
    I. R. Efimov
    M. Michels
    M. C. Verhaar
    R. de Weger
    A. Vink
    F. G. van Steenbeek
    A. F. Baas
    R. P. Davis
    H. W. Uh
    D. W. D. Kuster
    C. Cheng
    M. Mokry
    J. van der Velden
    F. W. Asselbergs
    M. Harakalova
    Clinical Epigenetics, 2021, 13
  • [39] Phenotypic variations in carriers of predicted protein-truncating genetic variants in MYBPC3: an autopsy-based case series
    Williams, Nod
    Marion, Robert
    McDonald, Thomas, V
    Wang, Dawei
    Zhou, Bo
    Eng, Lucy S.
    Um, Sung Yon
    Lin, Ying
    Ruiter, Kevin
    Rojas, Lisa
    Sampson, Barbara A.
    Tang, Yingying
    CARDIOVASCULAR PATHOLOGY, 2018, 37 : 30 - 33
  • [40] Absence of known feline MYH7 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy
    O'Donnell, K.
    Adin, D.
    Atkins, C. E.
    DeFrancesco, T.
    Keene, B. W.
    Tou, S.
    Meurs, K. M.
    ANIMAL GENETICS, 2021, 52 (04) : 542 - 544
12345